Skip to content
Menu

Teva Pharmaceutical Industries Limited TEVJF

Full chart Compare
Set alert

Price alert · TEVJF

All alert types
38.98 USD 0.00 (+0.00%)

Regular-session close

32.89 Day range 38.98
14.32 52-week range 39.70
YTD
+36.25%
1 year
+118.99%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

0.89 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 23.3×
P/S 1.9×
P/B 4.1×
P/FCF 12.8×
EV/EBITDA 8.7×
EV/Sales 2.7×
FCF Yield 7.8%

Profitability

Gross Margin 51.8%
Operating Margin 12.5%
Net Margin 8.9%
ROE 19.3%
ROIC 7.4%
ROA 3.7%

Growth (YoY)

Revenue 4.3%
Operating Income 811.9%
EPS (diluted) 183.4%
Free Cash Flow 241.4%

Financial Health

Current Ratio 1.0×
Quick Ratio 0.8×
Debt / Equity 2.2×
Net Debt / EBITDA 2.5×
Interest Coverage 2.1×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31